Bramson J - Search Results

1

Immediate Dysfunction of Vaccine-Elicited CD8+ T Cells Primed in the Absence of CD4+ T Cells.

Provine NM, Larocca RA, Aid M, Penaloza-MacMaster P, Badamchi-Zadeh A, Borducchi EN, Yates KB, Abbink P, Kirilova M, Ng'ang'a D, Bramson J, Haining WN, Barouch DH. Provine NM, et al. Among authors: bramson j. J Immunol. 2016 Sep 1;197(5):1809-22. doi: 10.4049/jimmunol.1600591. Epub 2016 Jul 22. J Immunol. 2016. PMID: 27448585 Free PMC article.

2

A double recombinant adenovirus expressing the costimulatory molecule B7-1 (murine) and human IL-2 induces complete tumor regression in a murine breast adenocarcinoma model.

Emtage PC, Wan Y, Bramson JL, Graham FL, Gauldie J. Emtage PC, et al. Among authors: bramson jl. J Immunol. 1998 Mar 1;160(5):2531-8. J Immunol. 1998. PMID: 9498799

3

Dendritic cell-derived IL-12 is not required for the generation of cytotoxic, IFN-gamma-secreting, CD8(+) CTL in vivo.

Wan Y, Lu L, Bramson JL, Baral S, Zhu Q, Pilon A, Dayball K. Wan Y, et al. Among authors: bramson jl. J Immunol. 2001 Nov 1;167(9):5027-33. doi: 10.4049/jimmunol.167.9.5027. J Immunol. 2001. PMID: 11673511

4

Electroporation enables plasmid vaccines to elicit CD8+ T cell responses in the absence of CD4+ T cells.

Dayball K, Millar J, Miller M, Wan YH, Bramson J. Dayball K, et al. Among authors: bramson j. J Immunol. 2003 Oct 1;171(7):3379-84. doi: 10.4049/jimmunol.171.7.3379. J Immunol. 2003. PMID: 14500631

5

Detailed analysis of the CD8+ T-cell response following adenovirus vaccination.

Yang TC, Dayball K, Wan YH, Bramson J. Yang TC, et al. Among authors: bramson j. J Virol. 2003 Dec;77(24):13407-11. doi: 10.1128/jvi.77.24.13407-13411.2003. J Virol. 2003. PMID: 14645597 Free PMC article.

6

A switch in costimulation from CD28 to 4-1BB during primary versus secondary CD8 T cell response to influenza in vivo.

Bertram EM, Dawicki W, Sedgmen B, Bramson JL, Lynch DH, Watts TH. Bertram EM, et al. J Immunol. 2004 Jan 15;172(2):981-8. doi: 10.4049/jimmunol.172.2.981. J Immunol. 2004. PMID: 14707071

7

CTL-dependent and -independent antitumor immunity is determined by the tumor not the vaccine.

Leitch J, Fraser K, Lane C, Putzu K, Adema GJ, Zhang QJ, Jefferies WA, Bramson JL, Wan Y. Leitch J, et al. Among authors: bramson jl. J Immunol. 2004 May 1;172(9):5200-5. doi: 10.4049/jimmunol.172.9.5200. J Immunol. 2004. PMID: 15100257

8

Cutaneous antigen priming via gene gun leads to skin-selective Th2 immune-inflammatory responses.

Alvarez D, Harder G, Fattouh R, Sun J, Goncharova S, Stämpfli MR, Coyle AJ, Bramson JL, Jordana M. Alvarez D, et al. Among authors: bramson jl. J Immunol. 2005 Feb 1;174(3):1664-74. doi: 10.4049/jimmunol.174.3.1664. J Immunol. 2005. PMID: 15661930

9

Recombinant adenovirus vaccines can successfully elicit CD8+ T cell immunity under conditions of extreme leukopenia.

Grinshtein N, Yang TC, Parsons R, Millar J, Denisova G, Dissanayake D, Leitch J, Wan Y, Bramson J. Grinshtein N, et al. Among authors: bramson j. Mol Ther. 2006 Feb;13(2):270-9. doi: 10.1016/j.ymthe.2005.09.018. Epub 2005 Nov 16. Mol Ther. 2006. PMID: 16297666 Free article.

10

Development of cell-based tuberculosis vaccines: genetically modified dendritic cell vaccine is a much more potent activator of CD4 and CD8 T cells than peptide- or protein-loaded counterparts.

Malowany JI, McCormick S, Santosuosso M, Zhang X, Aoki N, Ngai P, Wang J, Leitch J, Bramson J, Wan Y, Xing Z. Malowany JI, et al. Among authors: bramson j. Mol Ther. 2006 Apr;13(4):766-75. doi: 10.1016/j.ymthe.2005.10.018. Epub 2005 Dec 15. Mol Ther. 2006. PMID: 16343993 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

199 results

Search Page